Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- ASKA Launches Leuplin Generic
February 21, 2014
- Diabetes Drug Sales Up 10% in 2013 Japan Market, Spurred by DPP-4 Inhibitors: IMS
February 21, 2014
- Plavix Tops Japan Ethical Drug Ranking, Sales Leap 14%: IMS
February 21, 2014
- US FDA Approves Droxidopa: DSP
February 20, 2014
- MTPC, Daiichi Sankyo Aim to Boost Sales of Struggling Tenelia
February 20, 2014
- RaQualia, Nagoya University Sign Industry-Academia Partnership Deal
February 20, 2014
- Future Relationship of Nichi-Iko and Sanofi in Question with Discontinuation of Biosimilar Codevelopment; Will They Continue to Work Together for Second AG?
February 20, 2014
- Astellas, AVEO Jettison Joint Development of Anticancer Agent Tivozanib
February 19, 2014
- Fujifilm Accepts Subscription Rights to J-TEC’s New Shares at 540 Million Yen, Commissioning Regenerative Medicine Products
February 19, 2014
- Eiken Chemical Taps Sales Division Head as New President
February 18, 2014
- US Biotech Acucela Makes Debut on TSE’s Mothers Market
February 18, 2014
- MTPC, JB to End Copromotion of Blood Plasma Products
February 18, 2014
- Nissan Chemical Sues Three More Generic Makers over Livalo Patent Infringement
February 18, 2014
- Daiichi Sankyo, UMN Pharma Sign Collaborative Research Deal for Norovirus Vaccine
February 18, 2014
- Blopress AGs Approved, Yet Blurry Prospect for Their June Listing
February 17, 2014
- Kissei, Alteogen Agree on Business Collaboration for Biosimilar Development
February 17, 2014
- LEO Pharma’s New Japan Head Takes Office
February 17, 2014
- Once-Monthly Injectable Abilify Maintena Approved in Canada: Otsuka, Lundbeck
February 17, 2014
- New Suspicion Hints Close Link between Novartis, SIGN Initiator Group
February 17, 2014
- Nichi-Iko on Tap to Enter US Market, Remicade Biosimilar Debut Eyed around 2018
February 14, 2014
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…